pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
HELUS Pharma · news · pharmadog
← back to HELUS Pharma
News mentioning HELUS Pharma
8
stories
3d
Helus Pharma notches successful Phase 3 depression readout
endpoints
3d
Serious adverse events mar robust efficacy data for Helus’ psychedelic in major depression
biospace
3d
STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions
stat
3d
Helus' chemically modified psychedelic hits key goals in phase 3 depression trial
fiercebiotech
Aug 6, 26
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Jul 18, 26
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
fiercebiotech
Apr 24, 26
Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months
endpoints